» Articles » PMID: 21714700

Mean Platelet Volume/platelet Count Ratio As a Predictor of Long-term Mortality After Non-ST-elevation Myocardial Infarction

Overview
Journal Platelets
Publisher Informa Healthcare
Specialty Hematology
Date 2011 Jul 1
PMID 21714700
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies reported an association between elevated mean platelet volume (MPV) and post-myocardial infarction mortality. This study explores the association between long-term mortality after non-ST-segment elevation myocardial infarction (NSTEMI) and the peripheral blood platelet indices (i.e., the mean platelet volume (MPV), platelet count, and the MPV/platelet (MPV/P) ratio). Two physicians independently reviewed the data of 619 NSTEMI patients. The blood samples were drawn and analyzed within 1 h of admission, the second, and the last hospital days. Patients were stratified into equal tertiles according to the platelet count, MPV, and MPV/platelet ratio. The primary outcome, 4-year all-cause mortality, was compared among the platelet indices tertile models. According to MPV, platelet count, and MPV/platelet ratio tertile models, there was a trend of higher 4-year mortality for the lower and upper tertiles in comparison to the middle tertiles. However, only the admission MPV/platelet ratio tercile model was statistically significant for predicting the 4-year mortality. The mortality rate of the highest MPV/platelet (48/207 (23%)) and the lowest (41/206 (20%)) tertiles were significantly higher than the middle tertile (19/206 (9%)), p = 0.0004 by the chi-squared test. After adjusting for Global Registry of Acute Coronary Events, the patients in the combined first and third MPV/P tertiles had higher mortality in reference to those in the middle MPV/P tercile (hazard ratio 1.951, confidence interval 1.032-3.687, and p < 0.0396). Our novel finding is that the MPV/platelet ratio is superior to the MPV alone in predicting long-term mortality after NSTEMI. We suggest that using this ratio will magnify any existing relationship between platelet indices and mortality post-NSTMI. Further studies are needed to confirm our finding.

Citing Articles

Biomedical application of TiONPs can cause arterial thrombotic risks through triggering procoagulant activity, activation and aggregation of platelets.

Bian Y, Jin Q, He J, Ngo T, Bae O, Xing L Cell Biol Toxicol. 2024; 40(1):67.

PMID: 39110362 PMC: 11306309. DOI: 10.1007/s10565-024-09908-y.


Modifying platelets at their birth: anti-thrombotic therapy without haemorrhage.

Feely C, Kaushal N, DAvino P, Martin J Front Pharmacol. 2024; 15:1343896.

PMID: 38562457 PMC: 10982340. DOI: 10.3389/fphar.2024.1343896.


Correlation of Hemoglobin Level With New Inflammatory Markers in the Emergency Department: A Retrospective Study Exploring Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte, and Mean Platelet Volume-to-Platelet Count Ratios.

Hassan M, Abdayem C, El Daouk S, Matar B Cureus. 2024; 16(3):e55401.

PMID: 38562344 PMC: 10984368. DOI: 10.7759/cureus.55401.


Mean Platelet Volume/Platelet Count Ratio as a Predictor of Both Incidence and Prognosis of Acute Ischemic Stroke in Hemodialysis Patients.

Ma L, Han Q, Sun F, Zhu K, Sun Q Int J Gen Med. 2023; 16:3985-3994.

PMID: 37674583 PMC: 10479580. DOI: 10.2147/IJGM.S416817.


Mean Platelet Volume to Platelet Count Ratio Predicts Left Atrial Stasis in Patients with Non-Valvular Atrial Fibrillation.

Liu X, Yu S, Liang T, Chen L, Zhang H Int J Gen Med. 2023; 16:847-858.

PMID: 36895511 PMC: 9990455. DOI: 10.2147/IJGM.S395305.